1. C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer. Issue 3 (15th March 2022) Authors: Klümper, Niklas; Saal, Jonas; Berner, Fiamma; Lichtensteiger, Christa; Wyss, Nina; Heine, Annkristin; Bauernfeind, Franz Georg; Ellinger, Jörg; Brossart, Peter; Diem, Stefan; Schmid, Sabine; Joerger, Markus; Frueh, Martin; Ritter, Manuel; Hölzel, Michael; Flatz, Lukas; Bald, Tobias Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. (May 2022) Authors: Klümper, Niklas; Sikic, Danijel; Saal, Jonas; Büttner, Thomas; Goldschmidt, Franziska; Jarczyk, Jonas; Becker, Philippe; Zeuschner, Philip; Weinke, Maximilian; Kalogirou, Charis; Breyer, Johannes; Burger, Maximilian; Nuhn, Philipp; Tully, Karl; Roghmann, Florian; Bolenz, Christian; Zengerling, Fr... Journal: European journal of cancer Issue: Volume 167(2022) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTLA4, PD-1, PD-L1, PD-L2, TIM-3, TIGIT, and LAG3 DNA Methylation Is Associated With BAP1-Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma. Issue 7 (22nd September 2022) Authors: de Vos, Luka; Carrillo Cano, Tzaitel Maria; Zarbl, Romina; Klümper, Niklas; Ralser, Damian Johannes; Franzen, Alina; Herr, Emmanuelle; Gabrielpillai, Jennis; Vogt, Timo Jakob; Dietrich, Jörn; Strieth, Sebastian; Landsberg, Jennifer; Dietrich, Dimo Journal: Journal of immunotherapy Issue: Volume 45:Issue 7(2022) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma. Issue 12 (6th December 2021) Authors: Klümper, Niklas; Schmucker, Philipp; Hahn, Oliver; Höh, Benedikt; Mattigk, Angelika; Banek, Severine; Ellinger, Jörg; Heinzelbecker, Julia; Sikic, Danijel; Eckstein, Markus; Strauß, Arne; Zengerling, Friedemann; Hölzel, Michael; Zeuschner, Philip; Kalogirou, Charis Journal: Clinical & translational immunology Issue: Volume 10:Issue 12(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial. Issue 2 (2nd April 2023) Authors: Saal, Jonas; Bald, Tobias; Eckstein, Markus; Ritter, Manuel; Brossart, Peter; Ellinger, Jörg; Hölzel, Michael; Klümper, Niklas Journal: JNCI cancer spectrum Issue: Volume 7:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma. Issue 1 (December 2016) Authors: Schrödter, Sarah; Braun, Martin; Syring, Isabella; Klümper, Niklas; Deng, Mario; Schmidt, Doris; Perner, Sven; Müller, Stefan; Ellinger, Jörg Journal: Molecular cancer Issue: Volume 15:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma. Issue 1 (30th March 2020) Authors: Klümper, Niklas; Ralser, Damian J; Bawden, Emma Grace; Landsberg, Jenny; Zarbl, Romina; Kristiansen, Glen; Toma, Marieta; Ritter, Manuel; Hölzel, Michael; Ellinger, Jörg; Dietrich, Dimo Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer. Issue 8 (4th October 2021) Authors: Ralser, Damian J.; Klümper, Niklas; Gevensleben, Heidrun; Zarbl, Romina; Kaiser, Christina; Landsberg, Jennifer; Hölzel, Michael; Strieth, Sebastian; Faridi, Andree; Abramian, Alina; Dietrich, Dimo Journal: Journal of immunotherapy Issue: Volume 44:Issue 8(2021) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Molecular and Immune Correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA Methylation in Triple Negative Breast Cancer. Issue 8 (October 2021) Authors: Ralser, Damian J.; Klümper, Niklas; Gevensleben, Heidrun; Zarbl, Romina; Kaiser, Christina; Landsberg, Jennifer; Hölzel, Michael; Strieth, Sebastian; Faridi, Andree; Abramian, Alina; Dietrich, Dimo Journal: Journal of immunotherapy Issue: Volume 44:Issue 8(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. N6‐Methyladenosine (m6A) readers are dysregulated in renal cell carcinoma. Issue 5 (23rd March 2021) Authors: von Hagen, Felix; Gundert, Larissa; Strick, Alexander; Klümper, Niklas; Schmidt, Doris; Kristiansen, Glen; Tolkach, Yuri; Toma, Marieta; Ritter, Manuel; Ellinger, Jörg Journal: Molecular carcinogenesis Issue: Volume 60:Issue 5(2021) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗